ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2736

Female Specific Increase in T Cell Glycosylation in Lupus

Gabriela Gorelik1 and Bruce Richardson2, 1Internal Medicine, University of Michigan, Ann Arbor, MI, 2Rheumatology, University of Michigan, Ann Arbor, MI

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: epigenetics and glycoproteins, Lupus, T cells

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: T cell Biology in Lupus, Vasculitis, Myositis and Other Autoimmunity

Session Type: Abstract Submissions (ACR)

Background/Purpose: Systemic Lupus Erythematosus (SLE) is an autoimmune inflammatory disease characterized by altered T cell signaling. SLE is characterized by epigenetic mechanisms that cause hypomethylation of the inactive X-chromosome predisposing females to the disease, and a global T cell DNA hypomethylation, which causes overexpression of immune-related genes.

OGT (O-linked N-acetylglucosamine transferase) is an X-linked gene overexpressed in female lupus T cells. OGT causes posttranslational modifications to proteins by adding β-N-acetyl-glucosamine (O-GlcNAc) to Ser or Thr residues in competition with phosphorylation. OGT mRNA and protein levels and O-GlcNAc-modified proteins are increased in CD4+ experimentally demethylated T cells and in T cells from active women with lupus.

Recent evidence shows that OGT plays a critical role in chromatin structure through O-GlcNAcylation of histones in vivo and in vitro, and GlcNAc is considered now part of the histone code.

Hypothesis:  OGT overexpression in female lupus alters T cell signaling affecting posttranslational modifications of histones, thereby regulating chromatin remodeling and modifying gene expression.

Methods: PBMC from healthy donors were PHA-stimulated and treated with 5-azaC for 72 h. Then CD4+ T cells were isolated by negative selection and stimulated with PMA/Ionomycin for 6 h. T cells from lupus patients were activated with PMA/Ionomycin for 6 h. Cell fractions were obtained by using a nuclear extract kit (Active Motif) and the chromatin-bound proteins were isolated from the insoluble nuclear fraction. Subcellular fractions were subjected to SDS-PAGE gel electrophoresis followed by immunoblot. To detect glycosylated proteins we used CTD110.6 antibody (Abcam) and histone glycosylation was specifically detected by using anti-Histone H2B (glcnac S112) antibody (Abcam). T cells were nucleofected with 2µg of OGT siRNA using a nucleofector device (Amaxa).  

Results: OGT and GlcNAcylated protein levels were increased in the nuclear fraction which correlates with translocation of OGT to the nucleus after lymphocyte activation, and the increment was higher in experimentally demethylated T cells, (OGT: p=0.047 control vs 5-AzaC T cells; GlcNAcylated proteins: p=0.047 control vs 5-AzaC T cells). OGT levels in T cells from males did not show any significant difference regardless of the treatment and/or cell fraction.  We also found OGT bound to chromatin-bound proteins. H2B was GlcNAcylated at Ser112 in T cells and increased in women patients with active lupus with respect to healthy female donors (mean ± SEM: 2.85 ± 0.95; p<0.05 vs healthy donors; n=3). Histone glycosylation was inhibited in T cells transfected with OGT siRNA by 81 ± 11%, indicating the specificity of the effect.

Conclusion: These results support our hypothesis that OGT overexpression in lupus T cells causes modifications in histone glycosylation that may result in altered gene expression.


Disclosure:

G. Gorelik,
None;

B. Richardson,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/female-specific-increase-in-t-cell-glycosylation-in-lupus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology